Fanconi anemia is a highly penetrant cancer suscep...[Haematologica. 2008]

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: Haematologica. 2008 Apr;93(4):486-8. Links

Comment on:: Haematologica. 2008 Apr;93(4):511-7.

Fanconi anemia is a highly penetrant cancer susceptibility syndrome.

Dokal I.

Academic Unit of Paediatrics, Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, London, England. i.dokal@qmul.ac.uk

PMID: 18379006 [PubMed - indexed for MEDLINE]

Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry.
Haematologica. 2008 Apr; 93(4):511-7. Epub 2008 Mar 5.

[Haematologica. 2008]
ReviewFanconi anemia (cross)linked to DNA repair.
Cell. 2005 Dec 29; 123(7):1191-8.

[Cell. 2005]
Review[Fanconi anemia: cellular and molecular features]
Pathol Biol (Paris). 2007 Feb; 55(1):19-28. Epub 2006 Aug 10.

[Pathol Biol (Paris). 2007]
ReviewFanconi anemia: current management.
Hematology. 2005; 10 Suppl 1:108-10.

[Hematology. 2005]
ReviewMolecular pathogenesis of Fanconi anemia: recent progress.
Blood. 2006 Jun 1; 107(11):4223-33. Epub 2006 Feb 21.

[Blood. 2006]
» See reviews... | » See all...

Recent Activity

Clear Turn Off Turn On

Fanconi anemia is a highly penetrant cancer susceptibility syndrome.Fanconi anemia is a highly penetrant cancer susceptibility syndrome.

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show

Fanconi anemia is a highly penetrant cancer susceptibility syndrome.

Related articles

Recent Activity